Results 171 to 180 of about 114,221,800 (220)

Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada. [PDF]

J Infect Dis
Skowronski DM, Ranadheera C, Kaweski SE, Sabaiduc S, Separovic L, Makowski G, Ung J, Reyes RC, Henry B, Albert A, Clemens F, Kobasa D, Bastien N.   +12 more
europepmc   +1 more source

CRISPR/Cas12a2-Mediated Ultrasensitive Assay for Rapid Detection of H1N1 Influenza Virus RNA. [PDF]

ACS Omega
Wen C, Min X, Yu H, Jin K, Jing W, Wang F, Cheng X, Luo L, Feng M.   +8 more
europepmc   +1 more source

Post-Pandemic Genomic Diversity and Lineage Turnover of Influenza Viruses in Mexico During 2022-2023. [PDF]

Viruses
Taboada B, Zárate S, Muñoz-Medina JE, Vazquez-Perez JA, Sanchez-Flores A, Salas-Lais AG, Junco AU, Zárate A, Fernandes-Matano L, Uribe-Noguez LA, Mendoza-Ramírez E, Mejía-Nepomuceno F, Arias CF.   +12 more
europepmc   +1 more source

Occupationally Exposed and General Population Antibody Profiles to Influenza A Viruses Circulating in Swine as Indication of Zoonotic Risk. [PDF]

Emerg Infect Dis
Snyder CA, Janzen GM, Zanella GC, Moraes DCA, Silva GS, Santos JJS, Drapeau EM, Hensley SE, Anderson TK, Gauger PC, Baker AL.   +10 more
europepmc   +1 more source

Longitudinal assessment of functional antibodies to a novel influenza virus strain across age groups. [PDF]

PLoS Pathog
Huckriede A, Hoorn I, Joshi M, de Vries-Idema J, Vidarsson G, van Kasteren PB, Beukema M.   +6 more
europepmc   +1 more source

Contribution of E190D and Q226H Mutations in HA to the Receptor-Binding Profile of D1.1 Genotype H5N1 Viruses. [PDF]

Influenza Other Respir Viruses
Fang Y, Yang L, Zou S, Liu L, Zhu W, Wang D.   +5 more
europepmc   +1 more source

Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026. [PDF]

Euro Surveill
Felix Garza Z, Eggink D, Bagheri M, van den Brink S, Goderski G, Pronk M, Lexmond P, Hooiveld M, van Gageldonk-Lafeber R, Koel B, Fouchier R, Meijer A.   +11 more
europepmc   +1 more source

Increased burden of influenza A/H1N1pdm09 in older adults following the COVID-19 pandemic

Jong SPJd, Russell CA.
europepmc   +1 more source

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1 [PDF]

Journal of Biomedical Research, 2015
This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The docking result showed that AD3BF2D ligand (N-[(1S,6R)-5-
Usman Sumo Friend Tambunan, Arli Aditya Parikesit, Rizky Arcinthya Rachmania   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Drug design for Influenza A virus subtype H1N1

Journal of the Taiwan Institute of Chemical Engineers, 2010
Abstract An outbreak of influenza A virus subtype H1N1, also known as swine flu, in Mexico was occurred in April 2009. To design drugs for treating this epidemic is urgency. In this study, we employed the new sequences (2009) to build the N1 simulation structure by homology modeling, which has been checked for high reliability by Verify Score and ...
Fuu-Jen Tsai, Calvin Yu-Chian Chen, Hung-Jin Huang   +2 more
exaly   +2 more sources